Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda source : Www.aquestive.com save search
Aquestive Therapeutics Receives Conditional FDA Acceptance of Proprietary Name Anaphylm™ for Lead Candidate AQST-109 (Epinephrine Sublingual Film)
Published: 2023-04-20 (Crawled : 12:20) - aquestive.com
AQST | $4.085 -4.56% 890K
|
Health Technology
|
| O: 1.45%
H: 2.86%
C: -1.43%
aqst-109 fda candidate therapeutics
Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film)
Published: 2022-12-22 (Crawled : 13:20) - aquestive.com
AQST | $4.085 -4.56% 890K
|
Health Technology
|
| O: -0.38%
H: 5.5%
C: 0.22%
aqst-109 fda meeting therapeutics phase 2
Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film
Published: 2022-10-11 (Crawled : 12:20) - aquestive.com
AQST | $4.085 -4.56% 890K
|
Health Technology
|
| O: 1.96%
H: 8.65%
C: 3.85%
aqst-109 fda therapeutics response epinephrine positive
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
Published: 2022-08-31 (Crawled : 12:20) - aquestive.com
AQST | $4.085 -4.56% 890K
|
Health Technology
|
| O: -6.58%
H: 3.52%
C: 1.76%
fda tentative approval therapeutics
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.